Ongoing CE Activities

14th Annual School of Breast Oncology® Online

2017 NCCN Case Manager and Medical Director Program: Updates in the Management of Breast Cancer

34th Annual Miami Breast Cancer Conference® Clinical Case Vignette Series™

Adding Evidence to Front-Line Therapy of Hormone Receptor–Positive Breast Cancer (login required)

Adipose Fat Distribution a CVD Risk After Breast Cancer

Assisting Community-Based Oncologists and Surgeons in Making Treatment Decisions for Patients with ER-Positive, HER2-Negative Early Breast Cancer

NCCN 2018 Congress Webinar Series: Breast Cancer – Barriers to the Coordination of Cancer Care

NCCN 2018 Congress Webinar Series: Breast Cancer – Surveillance of Patients With Early Stage and Advanced Disease

Breast Cancer Update, Issue 3, 2019: ER-Positive Edition

Breast Cancer Update: Triple-Negative Edition

Conversations with Oncology Investigators: Bridging the Gap between Research and Patient Care

CDK 4/6 Inhibition in Breast Cancer: Self-Study Module II

CDK 4/6 Inhibition in Breast Cancer: Self-Study Module I

CDK4/6 Inhibitors: Moving Beyond the Breast Cancer Setting

Interactive Tumor Panel: Clinical Investigators Discuss Emerging Research and Actual Cases of Patients with Breast Cancer

Cases from the Community: Clinical Investigators Provide Their Perspectives on Actual Breast Cancer Cases and the Implications of Emerging Research

Community Practice Connections™: CDK4/6 Inhibitors With the Experts: The Role of Emerging Agents for the Management of Metastatic Breast Cancer

Consensus or Controversy, Issue 2: Clinical Investigators Provide Their Perspectives on Controversial Issues in the Management of HER2-Positive Breast Cancer (login required)

Data + Perspectives: Clinical Investigators Explore the Emerging Role of PARP Inhibition in the Management of Breast Cancer

Elevated Breast Cancer Risk With HRT Persists

Evolving Standards in HER2-Targeted Adjuvant Therapy (login required)

Genetic/Familial High-Risk Evaluation in Patients with Breast Cancer

Herceptin: 6 or 12 Months?

Hormone Receptor-Positive Advanced Breast Cancer: Challenges and New Treatment Options

Hormone Receptor-Positive Advanced Breast Cancer: Will ESR1 Have a Role? (login required)

Implementation and Implications of AJCC Cancer Staging Manual, 8th Edition for Breast Cancer Staging

Empowering Oncology Teams to Improve Care Quality for Women with Advanced or Metastatic HR+/HER2- Breast Cancer

Clinical Strategies for Incorporating Immunotherapy in Advanced Breast Cancer: Insights for Surgeons and Oncologists

Male Breast Cancer as a Second Primary Cancer: Increased Risk Following Lymphoma

Management of HR-Positive Advanced Breast Cancer: Is There a Best Sequence? (login required)

Management of Lymphedema after Breast Cancer Treatment

Medical Crossfire®: Establishing the Role of Predictive Biomarkers and Testing Strategies for Breast Cancer Management

Medical Crossfire®: Expert Perspectives on the Emerging Role of CDK4/6 Inhibitors for the Management of Metastatic Breast Cancer

NCCN Congress Series: Breast Cancer with Updates from the 2019 San Antonio Breast Cancer Symposium

NCCN Continuing Education in Breast Cancer

NCCN Guidelines Insights: Breast Cancer, Version 3.2018

Oncology Grand Rounds Series: Part 3 — Breast Cancer: A satellite symposium held at the 2017 ONS Annual Congress

Oncology Grand Rounds: Breast Cancer

Beyond the Guidelines: Investigator Perspectives on Current Clinical Issues and Ongoing Research in the Management of Early and Advanced Breast Cancer

Consensus or Controversy? Clinical Investigators Provide Perspectives on Practical Issues and Ongoing Research Related to the Management of Breast Cancer

Predictors of Disruptions in Breast Cancer Care for Individuals with Schizophrenia

Prioritizing Women With Dense Breasts for Supplemental Imaging

Proton-Beam RT Proves Safe, Effective in Breast Cancer

Significance and Relevance of Recent Data Sets and Publications in the Management of Breast Cancer

Recorded Presentations From the NCCN 2017 Congress Webinar Series: Breast Cancer

Response to PD-L1 Drug Boosts Survival in TNBC

Real-World Strategies to Transform a Triple-Negative Breast Cancer Diagnosis Into Positive Patient Outcomes

Taxane-Based Tx May Put Breast Ca Patients Off Balance

TNBC: Improvements Gained With PD-1/L1 Inhibitors

Use of Genomic Classifiers to Inform Clinical Decision-Making for Patients with Early Breast Cancer

Data + Perspectives: Biologic Basis and Available Clinical Research Underlying the Protocol and Nonresearch Use of PARP Inhibition in Patients with Ovarian and Breast Cancer

Virtual Molecular Tumor Board - A Webcast Series Exploring the Role of Molecular Profiling in Metastatic Breast Cancer (login required)

Virtual Patient Simulation: Case Studies in Early Stage HER2+ Breast Cancer (login required)

What Would You Do? Managing HR-Positive Advanced Breast Cancer

Year in Review: Proceedings from the Multitumor Regional Symposium Focused on the Application of Emerging Research Information to the Care of Patients with Common Cancers